Marché européen des dispositifs vasculaires périphériques et de cardiologie interventionnelle – Tendances et prévisions du secteur jusqu’en 2029

Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché européen des dispositifs vasculaires périphériques et de cardiologie interventionnelle – Tendances et prévisions du secteur jusqu’en 2029

  • Medical Devices
  • Publish Reports
  • Feb 2022
  • Europe
  • 350 Pages
  • Nombre de tableaux : 328
  • Nombre de figures : 49

Europe Interventional Cardiology Peripheral Vascular Devices Market

Taille du marché en milliards USD

TCAC :  % Diagram

Diagram Période de prévision
1 –0
Diagram Taille du marché (année de référence)
MILLIONS DE DOLLARS AMÉRICAINS
Diagram Taille du marché (année de prévision)
MILLIONS DE DOLLARS AMÉRICAINS
Diagram TCAC
%
Diagram Principaux acteurs du marché
  • Medtronic
  • BD
  • SMT Cordis
  • Abbott
  • Boston Scientific

>Marché européen de la cardiologie interventionnelle et des dispositifs vasculaires périphériques, par produit ( ballons d'angioplastiestents , cathéters, endoprothèses de réparation d'anévrisme endovasculaire, filtres de veine cave inférieure (VCI), dispositifs de modification de plaque, accessoires et dispositifs de modification du flux hémodynamique.), type (conventionnel et standard), procédure (intervention iliaque, interventions fémoro-poplitées, interventions tibiales (sous le genou), angioplastie périphérique, thrombectomie artérielle et athérectomie périphérique), indication (maladie artérielle périphérique et intervention coronarienne), groupe d'âge (gériatrie, adultes et pédiatrie), utilisateur final (hôpitaux, centres de chirurgie ambulatoire, établissements de soins infirmiers, cliniques et autres.), canal de distribution (appel d'offres direct, distributeurs tiers et autres), pays (Allemagne, Royaume-Uni, France, Italie, Espagne, Suisse, Pays-Bas, Russie, Turquie et Reste de l'Europe) Tendances et prévisions du secteur jusqu'en 2029

Marché européen de la cardiologie interventionnelle et des dispositifs vasculaires périphériques

Analyse et perspectives du marché  : Marché européen de la cardiologie interventionnelle et des dispositifs vasculaires périphériques

 Le marché européen de la cardiologie interventionnelle et des dispositifs vasculaires périphériques devrait connaître une croissance du marché au cours de la période de prévision de 2022 à 2029. Data Bridge Market Research analyse que le marché croît avec un TCAC de 7,0 % au cours de la période de prévision de 2022 à 2029 et devrait atteindre 6 188,28 millions USD d'ici 2029 contre 3 746,26 millions USD en 2021. La prévalence accrue des maladies coronariennes , des cardiopathies ischémiques et des maladies vasculaires, la sensibilisation accrue au traitement et à l'utilisation rapides des dispositifs, sont susceptibles d'être les principaux moteurs qui propulsent la demande du marché au cours de la période de prévision.

Le terme cardiologie interventionnelle désigne un domaine de la médecine relevant de la sous-spécialité de la cardiologie et des dispositifs vasculaires périphériques qui utilise des techniques diagnostiques améliorées, conventionnelles et avancées et d'autres techniques pour évaluer le débit sanguin et la pression dans les artères coronaires et les cavités du cœur, ainsi que des procédures techniques et des médicaments pour traiter les anomalies qui altèrent le fonctionnement du système cardiovasculaire. La cardiologie interventionnelle et les dispositifs vasculaires périphériques sont utilisés, car ils modifient le mode de vie sédentaire. Ils réduisent les complications des maladies cardiaques chroniques, telles que la maladie coronarienne, la cardiopathie ischémique et les maladies vasculaires.

Les maladies coronariennes sont la principale cause de décès chez les femmes. La connaissance des maladies cardiovasculaires et vasculaires peut favoriser un mode de vie sain. Une connaissance adéquate des symptômes et des facteurs de risque peut aider à réduire l'exposition de la population aux facteurs de risque modifiables et ainsi contribuer aux stratégies de prévention et de contrôle. La connaissance des symptômes des maladies cardiovasculaires et vasculaires permettrait un traitement rapide.

Les facteurs responsables de la croissance du marché européen de la cardiologie interventionnelle et des dispositifs vasculaires périphériques sont la prévalence accrue des maladies coronariennes, des cardiopathies ischémiques et des maladies vasculaires, la sensibilisation accrue au traitement et à l'utilisation rapides des dispositifs, les avancées technologiques dans la cardiologie et les dispositifs vasculaires périphériques, l'intérêt accru pour la chirurgie non invasive et les politiques de remboursement favorables. Cependant, les facteurs qui devraient freiner le marché sont l'augmentation du coût des dispositifs, les risques observés lors de l'utilisation des dispositifs, l'augmentation des rappels de produits et la disponibilité de traitements alternatifs. D'autre part, les initiatives stratégiques des acteurs du marché, l'augmentation des dépenses de santé, l'augmentation des activités de recherche et développement et la croissance de la population gériatrique peuvent constituer une opportunité pour la croissance du marché européen de la cardiologie interventionnelle et des dispositifs vasculaires périphériques. Le besoin d'expertise qualifiée, le manque d'infrastructures hospitalières et l'approbation réglementaire peuvent créer des défis pour le marché européen de la cardiologie interventionnelle et des dispositifs vasculaires périphériques.

Le rapport sur le marché européen de la cardiologie interventionnelle et des dispositifs vasculaires périphériques fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et local, analyse les opportunités en termes de poches de revenus émergentes, les changements dans la réglementation du marché, les approbations de produits, les décisions stratégiques, les lancements de produits, les expansions géographiques et les innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché, contactez-nous pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.

Marché européen de la cardiologie interventionnelle et des dispositifs vasculaires périphériques

Portée et taille du marché européen des dispositifs de cardiologie interventionnelle et vasculaires périphériques

Le marché européen de la cardiologie interventionnelle et des dispositifs vasculaires périphériques est classé en sept segments : produit, type, procédure, indication, tranche d'âge, utilisateur final et canal de distribution.

  • Sur la base du produit, le marché européen de la cardiologie interventionnelle et des dispositifs vasculaires périphériques est segmenté en ballons d'angioplastie, stents, cathéters , endoprothèses endovasculaires de réparation d'anévrisme, filtres de veine cave inférieure (VCI) , dispositifs de modification de plaque, accessoires et dispositifs de modification du flux hémodynamique. En 2022, le segment des ballons d'angioplastie devrait dominer le marché européen de la cardiologie interventionnelle et des dispositifs vasculaires périphériques en raison du risque accru de mode de vie sédentaire, du diagnostic et de la détection précoces des maladies artérielles périphériques par les dispositifs vasculaires périphériques, de l'augmentation du financement public et de la présence de politiques de remboursement dans les soins de santé en Europe.
  • On the basis of type, the Europe interventional cardiology and peripheral vascular devices market is segmented into conventional and standard. In 2022, the conventional segment is expected to dominate the Europe interventional cardiology and peripheral vascular devices market due to increased productivity of conventional angioplasty balloons and catheters in developing markets in Europe and ease of use and convenience.
  • On the basis of procedure, the Europe interventional cardiology and peripheral vascular devices market is segmented into iliac intervention, femoropopliteal interventions, tibial (below-the-knee) interventions, peripheral angioplasty, arterial thrombectomy and peripheral atherectomy. In 2022, the peripheral angioplasty segment is expected to dominate the Europe interventional cardiology and peripheral vascular devices market due to technological advancement with peripheral angioplasty devices and rise of untapped opportunities in the Europe market for the development and production of peripheral angioplasty devices.
  • On the basis of indication, the Europe interventional cardiology and peripheral vascular devices market is segmented into peripheral arterial disease and coronary intervention. In 2022, the peripheral arterial disease segment is expected to dominate the Europe interventional cardiology and peripheral vascular devices market due to increase in cases of peripheral arterial diseases, early diagnosis and detection of the peripheral
  • diseases and rise in funding and programmes by the government in Europe for the treatment of cardiac diseases.
  • On the basis of age group, the Europe interventional cardiology and peripheral vascular devices market is segmented into geriatric, adults and paediatric. In 2022, the geriatric segment is expected to dominate the Europe interventional cardiology and peripheral vascular devices market rise in count of geriatric population in the U.K., rise in chronic cardiac diseases and availability of healthcare policies for the elderly patients.
  • On the basis of end user, the Europe interventional cardiology and peripheral vascular devices market is segmented into hospitals, ambulatory surgery centers, nursing facilities, clinics and others. In 2022, the hospitals segment is expected to dominate the Europe interventional cardiology and peripheral vascular devices market due to rise in chronic cardiac disorders, such as coronary artery disease and vascular diseases, rise in patient population and presence of upcoming hospitals in Europe region.
  • On the basis of distribution channel, the Europe interventional cardiology and peripheral vascular devices market is segmented into direct tenders, third party distributors and others. In 2022, the third party distributors segment is expected to dominate the Europe interventional cardiology and peripheral vascular devices market due to flexibility and scalability in the business and market expansion in the European region.

Europe Interventional Cardiology and Peripheral Vascular Devices Market Country Level Analysis

The Europe interventional cardiology and peripheral vascular devices market is analysed and market size information is provided by product, type, procedure, indication, age group, end user and distribution channel.

The countries covered in the Europe interventional cardiology and peripheral vascular devices market report are Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Russia, Turkey and  Rest of Europe

  • In 2022, Germany is expected to dominate due to the presence of the largest consumer market with high GDP.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data. 

The growth potential for interventional cardiology and peripheral vascular devices in emerging economies and the strategic initiatives by market players are creating new opportunities in the Europe interventional cardiology and peripheral vascular devices market

Europe interventional cardiology and peripheral vascular devices market also provides you with detailed market analysis for every country growth in particular industry with the interventional cardiology and peripheral vascular devices sales, impact of advancement in the interventional cardiology and peripheral vascular devices and changes in regulatory scenarios with their support for the interventional cardiology and peripheral vascular devices market. The data is available for historic period 2019 to 2021.

Competitive Landscape and Europe Interventional Cardiology and Peripheral Vascular Devices Market Share Analysis

Europe interventional cardiology and peripheral vascular devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the interventional cardiology and peripheral vascular devices market.

Certaines des principales entreprises fournissant des dispositifs de cardiologie interventionnelle et vasculaires périphériques sont Medtronic, BD., SMT, Cordis., Abbott., Boston Scientific Corporation, Teleflex Incorporated, WLGore & Associates, Inc, Cook, AngioDynamics., Edwards Lifesciences Corporation., Biosensors International Group, Ltd., OrbusNeich Medical Company Limited, Merit Medical Systems., Terumo Medical Corporation, B. Braun Melsungen AG, MicroPort Scientific Corporation, Lepu Medical Technology(Beijing)Co.,Ltd et Koninklijke Philips NV, entre autres.

Les analystes DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.

Les initiatives stratégiques des acteurs du marché ainsi que les nouvelles avancées technologiques en matière de cardiologie interventionnelle et de dispositifs vasculaires périphériques en Europe comblent le fossé dans le traitement des plaies chroniques. 

Par exemple,

  • En mai 2014, Boston Scientific Corporation a annoncé dans sa salle de presse qu'elle avait signé un accord définitif pour acquérir la division interventionnelle de Bayer AG. Cette acquisition devrait permettre à Boston Scientific d'accroître le nombre de ses segments dans le domaine périphérique, notamment les catégories d'athérectomie et de thrombectomie. Cela a aidé l'entreprise à renforcer sa position sur le marché de la cardiologie interventionnelle.

La collaboration, les coentreprises et d'autres stratégies des acteurs du marché améliorent le marché de l'entreprise sur le marché de la cardiologie interventionnelle et des dispositifs vasculaires périphériques, ce qui offre également l'avantage à l'organisation d'améliorer son offre pour le marché européen de la cardiologie interventionnelle et des dispositifs vasculaires périphériques.

 


SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT SEGMENT LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL

4.2 PORTER'S FIVE FORCES MODEL

5 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 THE RISE IN PREVALENCE OF CHRONIC DISEASES, SUCH AS CORONARY ARTERY DISEASE, ISCHEMIC HEART DISEASE AND VASCULAR DISEASES

6.1.2 AWARENESS AMONG THE POPULATION ABOUT THE TREATMENT AND USE OF THE DEVICES

6.1.3 TECHNOLOGICAL ADVANCEMENTS IN THE CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES

6.1.4 FAVORABLE REIMBURSEMENT POLICIES

6.1.5 INCREASED INTEREST FOR MINIMALLY INVASIVE PROCEDURES

6.2 RESTRAINTS

6.2.1 RISE IN COST OF THE CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES

6.2.2 RISKS OBSERVED WHILE USING INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES

6.2.3 RISE IN PRODUCT RECALL

6.2.4 AVAILABILITY OF ALTERNATE TREATMENTS

6.3 OPPORTUNITIES

6.3.1 GROWING GERIATRIC POPULATION

6.3.2 RISING HEALTHCARE EXPENDITURE

6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS

6.3.4 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES

6.4 CHALLENGES

6.4.1 STRINGENT RULES & REGULATIONS

6.4.2 LACK OF HOSPITAL INFRASTRUCTURE

7 IMPACT OF COVID-19 PANDEMIC ON THE MARKET

7.1 PRICE IMPACT

7.2 IMPACT ON DEMAND

7.3 IMPACT ON SUPPLY CHAIN

7.4 STRATEGIC DECISIONS FOR MANUFACTURERS/ SERVICE PROVIDERS

7.5 CONCLUSION

8 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 ANGIOPLASTY BALLOONS

8.2.1 OLD/NORMAL BALLOONS

8.2.2 DRUG ELUTING BALLOONS

8.2.3 CUTTING AND SCORING BALLOONS

8.3 STENT

8.3.1 ANGIOPLASTY STENTS

8.3.2 CORONARY STENTS

8.3.2.1 BARE-METAL STENTS

8.3.2.2 DRUG-ELUTING STENTS (DES)

8.3.2.3 BIO ABSORBABLE STENTS

8.3.3 PERIPHERAL STENTS

8.3.4 OTHERS

8.4 CATHETERS

8.4.1 ANGIOGRAPHY CATHETERS

8.4.2 GUIDING CATHETERS

8.4.3 OTHERS

8.5 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

8.5.1 ABDOMINAL AORTIC ANEURYSM

8.5.2 THORACIC AORTIC ANEURYSM

8.6 INFERIOR VENA CAVA (IVC) FILTERS

8.6.1 RETRIEVABLE FILTERS

8.6.2 PERMANENT FILTERS

8.7 PLAQUE MODIFICATION DEVICES

8.7.1 THROMBECTOMY DEVICES

8.7.2 ATHERECTOMY DEVICES

8.8 HEMODYNAMIC FLOW ALTERATION DEVICES

8.8.1 EMBOLIC PROTECTION DEVICES

8.8.2 CHRONIC TOTAL OCCLUSION DEVICES

8.9 OTHERS AND ACCESSORIES

8.9.1 GUIDEWIRES

8.9.2 INTRODUCER SHEATHS

8.9.3 BALLOON INFLATION DEVICES

8.9.4 VASCULAR CLOSURE DEVICES

8.9.5 OTHERS

9 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE

9.1 OVERVIEW

9.2 CONVENTIONAL

9.2.1 STENTS

9.2.2 CATHETERS

9.2.3 GUIDEWIRES

9.2.4 VASCULAR CLOSURE DEVICES (VCD)

9.2.5 OTHERS

9.3 ADVANCED

9.3.1 BALLOON CATHETERS

9.3.2 STENT GRAFTS

10 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE

10.1 OVERVIEW

10.2 PERIPHERAL ANGIOPLASTY

10.2.1 ANGIOPLASTY BALLOONS

10.2.2 STENT

10.2.3 CATHETERS

10.2.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

10.2.5 INFERIOR VENA CAVA (IVC) FILTERS

10.2.6 PLAQUE MODIFICATION DEVICES

10.2.7 HEMODYNAMIC FLOW ALTERATION DEVICES

10.2.8 OTHERS AND ACCESSORIES

10.3 ILIAC INTERVENTION

10.3.1 ANGIOPLASTY BALLOONS

10.3.2 STENT

10.3.3 CATHETERS

10.3.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

10.3.5 INFERIOR VENA CAVA (IVC) FILTERS

10.3.6 PLAQUE MODIFICATION DEVICES

10.3.7 HEMODYNAMIC FLOW ALTERATION DEVICES

10.3.8 OTHERS AND ACCESSORIES

10.4 TIBIAL (BELOW-THE-KNEE) INTERVENTIONS

10.4.1 ANGIOPLASTY BALLOONS

10.4.2 STENT

10.4.3 CATHETERS

10.4.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

10.4.5 INFERIOR VENA CAVA (IVC) FILTERS

10.4.6 PLAQUE MODIFICATION DEVICES

10.4.7 HEMODYNAMIC FLOW ALTERATION DEVICES

10.4.8 OTHERS AND ACCESSORIES

10.5 ARTERIAL THROMBECTOMY

10.5.1 ANGIOPLASTY BALLOONS

10.5.2 STENT

10.5.3 CATHETERS

10.5.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

10.5.5 INFERIOR VENA CAVA (IVC) FILTERS

10.5.6 PLAQUE MODIFICATION DEVICES

10.5.7 HEMODYNAMIC FLOW ALTERATION DEVICES

10.5.8 OTHERS AND ACCESSORIES

10.6 PERIPHERAL ATHERECTOMY

10.6.1 ANGIOPLASTY BALLOONS

10.6.2 STENT

10.6.3 CATHETERS

10.6.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

10.6.5 INFERIOR VENA CAVA (IVC) FILTERS

10.6.6 PLAQUE MODIFICATION DEVICES

10.6.7 HEMODYNAMIC FLOW ALTERATION DEVICES

10.6.8 OTHERS AND ACCESSORIES

10.7 FEMOROPOPLITEAL INTERVENTIONS

10.7.1 ANGIOPLASTY BALLOONS

10.7.2 STENT

10.7.3 CATHETERS

10.7.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

10.7.5 INFERIOR VENA CAVA (IVC) FILTERS

10.7.6 PLAQUE MODIFICATION DEVICES

10.7.7 HEMODYNAMIC FLOW ALTERATION DEVICES

10.7.8 OTHERS AND ACCESSORIES

11 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION

11.1 OVERVIEW

11.2 PERIPHERAL ARTERIAL DISEASE

11.2.1 ATHEROSCLEROSIS

11.2.2 ABDOMINAL AORTIC ANEURYSM

11.2.3 LOWER EXTREMITY PERIPHERAL ARTERIAL DISEASE

11.2.4 SUPRA-INGUINAL ARTERIAL DISEASE

11.2.5 INFRA-INGUINAL ARTERIAL DISEASE

11.2.6 INFRA-POPLITEAL DISEASE

11.2.7 UPPER EXTREMITY OCCLUSIVE DISEASE

11.2.8 CAROTID ARTERY DISEASE

11.2.9 OTHERS

11.3 CORONARY INTERVENTION

11.3.1 ISCHEMIC HEART DISEASE

11.3.2 THORACIC AORTIC ANEURYSM

11.3.3 VALVE DISEASE

11.3.4 PERCUTANEOUS VALVE REPAIR OR REPLACEMENT

11.3.5 CONGENITAL HEART ABNORMALITIES

11.3.6 OTHERS

12 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP

12.1 OVERVIEW

12.2 GERIATRIC

12.3 ADULTS

12.4 PEDIATRIC

13 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER

13.1 OVERVIEW

13.2 HOSPITALS

13.2.1 PRIVATE

13.2.2 PUBLIC

13.3 AMBULATORY SURGICAL CENTERS

13.4 NURSING FACILITIES

13.5 CLINICS

13.6 OTHERS

14 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW

14.2 THIRD PARTY DISTRIBUTORS

14.3 DIRECT TENDER

14.4 OTHERS

15 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY

15.1 EUROPE

15.1.1 GERMANY

15.1.2 U.K.

15.1.3 FRANCE

15.1.4 ITALY

15.1.5 SPAIN

15.1.6 NETHERLANDS

15.1.7 SWITZERLAND

15.1.8 RUSSIA

15.1.9 TURKEY

15.1.10 REST OF EUROPE

16 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: EUROPE

17 SWOT ANALYSIS

18 COMPANY PROFILE

18.1 BOSTON SCIENTIFIC CORPORATION

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 COMPANY SHARE ANALYSIS

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENT

18.1.6 ACQUSITION

18.2 CORDIS.

18.2.1 COMPANY SNAPSHOT

18.2.2 REVENUE ANALYSIS

18.2.3 COMPANY SHARE ANALYSIS

18.2.4 PRODUCT PORTFOLIO

18.2.5 RECENT DEVELOPMENTS

18.2.6 PRODUCT LAUNCHES

18.3 ABBOTT

18.3.1 COMPANY SNAPSHOT

18.3.2 REVENUE ANALYSIS

18.3.3 COMPANY SHARE ANALYSIS

18.3.4 PRODUCT PORTFOLIO

18.3.5 RECENT DEVELOPMENTS

18.3.6 PRODUCT LAUNCHES

18.4 BD (2021)

18.4.1 COMPANY SNAPSHOT

18.4.2 REVENUE ANALYSIS

18.4.3 COMPANY SHARE ANALYSIS

18.4.4 PRODUCT PORTFOLIO

18.4.5 RECENT DEVELOPMENT

18.5 TERUMO CORPORATION

18.5.1 COMPANY SNAPSHOT

18.5.2 REVENUE ANALYSIS

18.5.3 COMPANY SHARE ANALYSIS

18.5.4 PRODUCT PORTFOLIO

18.5.5 RECENT DEVELOPMENTS

18.5.6 PARTNERSHIP

18.5.7 PRODUCT LAUNCH

18.6 ANGIODYNAMICS.(2021)

18.6.1 COMPANY SNAPSHOT

18.6.2 REVENUE ANALYSIS

18.6.3 PRODUCT PORTFOLIO

18.6.4 RECENT DEVELOPMENTS

18.7 B. BRAUN MELSUNGEN AG (2021)

18.7.1 COMPANY SNAPSHOT

18.7.2 REVENUE ANALYSIS

18.7.3 PRODUCT PORTFOLIO

18.7.4 RECENT DEVELOPMENTS

18.8 BIOSENSORS INTERNATIONAL GROUP, LTD.

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENT

18.9 CARDIOVASCULAR SYSTEMS, INC. (2021)

18.9.1 COMPANY SNAPSHOT

18.9.2 REVENUE ANALYSIS

18.9.3 PRODUCT PORTFOLIO

18.9.4 RECENT DEVELOPMENTS

18.1 COOK

18.10.1 COMPANY SNAPSHOT

18.10.2 PRODUCT PORTFOLIO

18.10.3 RECENT DEVELOPMENTS

18.10.4 EXPANSION

18.10.5 PRODUCT LAUNCHES

18.11 EDWARDS LIFESCIENCES CORPORATION

18.11.1 COMPANY SNAPSHOT

18.11.2 REVENUE ANALYSIS

18.11.3 PRODUCT PORTFOLIO

18.11.4 RECENT DEVELOPMENTS

18.12 KONINKLIJKE PHILIPS N.V.

18.12.1 COMPANY SNAPSHOT

18.12.2 REVENUE ANALYSIS

18.12.3 PRODUCT PORTFOLIO

18.12.4 RECENT DEVELOPMENTS

18.12.5 PRODUCT UPDATES

18.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. (2021)

18.13.1 COMPANY SNAPSHOT

18.13.2 REVENUE ANALYSIS

18.13.3 PRODUCT PORTFOLIO

18.13.4 RECENT DEVELOPMENT

18.14 MEDTRONIC

18.14.1 COMPANY SNAPSHOT

18.14.2 REVENUE ANALYSIS

18.14.3 PRODUCT PORTFOLIO

18.14.4 RECENT DEVELOPMENTS

18.14.5 COLLABORATION

18.14.6 PRODUCT LAUNCH

18.15 MERIT MEDICAL SYSTEM

18.15.1 COMPANY SNAPSHOT

18.15.2 REVENUE ANALYSIS

18.15.3 PRODUCT PORTFOLIO

18.15.4 RECENT DEVELOPMENTS

18.16 MICROPORT SCIENTIFIC CORPORATION.

18.16.1 COMPANY SNAPSHOT

18.16.2 REVENUE ANALYSIS

18.16.3 PRODUCT PORTFOLIO

18.16.4 RECENT DEVELOPMENTS

18.16.4.1 PRODUCT APPROVALS

18.17 ORBUSNEICH MEDICAL COMPANY LIMITED

18.17.1 COMPANY SNAPSHOT

18.17.2 PRODUCT PORTFOLIO

18.17.3 RECENT DEVELOPMENT

18.17.4 PRODUCT LAUNCH

18.18 SMT

18.18.1 COMPANY SNAPSHOT

18.18.2 PRODUCT PORTFOLIO

18.18.3 RECENT DEVELOPMENTS

18.19 TELEFLEX INCORPORATED.

18.19.1 COMPANY SNAPSHOT

18.19.2 REVENUE ANALYSIS

18.19.3 PRODUCT PORTFOLIO

18.19.4 RECENT DEVELOPMENTS

18.19.5 ACQUISITIONS

18.2 W. L. GORE & ASSOCIATES, INC.

18.20.1 COMPANY SNAPSHOT

18.20.2 PRODUCT PORTFOLIO

18.20.3 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

Liste des tableaux

TABLE 1 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 2 EUROPE ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 EUROPE ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 4 EUROPE STENT IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 5 EUROPE STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 6 EUROPE CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 7 EUROPE CATHETERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 EUROPE CATHETERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 9 EUROPE ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 EUROPE ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 11 EUROPE INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 EUROPE INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 13 EUROPE PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 EUROPE PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 15 EUROPE HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 EUROPE HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 17 EUROPE OTHER AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 EUROPE OTHER AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 19 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 20 EUROPE CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 EUROPE CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 22 EUROPE ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 EUROPE ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 24 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 25 EUROPE PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 EUROPE PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 27 EUROPE ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 EUROPE ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 29 EUROPE TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 EUROPE TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 31 EUROPE ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 EUROPE ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 33 EUROPE PERIPHERAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 EUROPE PERIPHERAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 35 EUROPE FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 EUROPE FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 37 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 38 EUROPE PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 EUROPE PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 40 EUROPE CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 EUROPE CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 42 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 43 EUROPE GERIATRIC IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 44 EUROPE ADULTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 45 EUROPE PEDIATRIC IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 46 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 47 EUROPE HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 48 EUROPE HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 49 EUROPE AMBULATORY SURGICAL CENTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 50 EUROPE NURSING FACILITIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 51 EUROPE CLINICS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 52 EUROPE OTHERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 53 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 54 EUROPE THIRD PARTY DISTRIBUTORS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 55 EUROPE DIRECT TENDER IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 56 EUROPE OTHERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 57 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 58 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 59 EUROPE ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 60 EUROPE STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 61 EUROPE CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 62 EUROPE CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 63 EUROPE ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 64 EUROPE INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 65 EUROPE PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 66 EUROPE HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 67 EUROPE OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 68 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 69 EUROPE CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 70 EUROPE ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 71 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 72 EUROPE ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 73 EUROPE FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 74 EUROPE TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 75 EUROPE PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 76 EUROPE ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 77 EUROPE PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 78 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 79 EUROPE PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 80 EUROPE CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 81 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 82 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 83 EUROPE HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 84 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 85 GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 86 GERMANY ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 87 GERMANY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 88 GERMANY CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 89 GERMANY CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 90 GERMANY ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 91 GERMANY INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 92 GERMANY PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 93 GERMANY HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 94 GERMANY OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 95 GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 96 GERMANY CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 97 GERMANY ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 98 GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 99 GERMANY ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 100 GERMANY FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 101 GERMANY TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 102 GERMANY PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 103 GERMANY ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 104 GERMANY PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 105 GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 106 GERMANY PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 107 GERMANY CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 108 GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 109 GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 110 GERMANY HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 111 GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 112 U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 113 U.K. ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 114 U.K. STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 115 U.K. CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 116 U.K. CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 117 U.K. ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 118 U.K. INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 119 U.K. PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 120 U.K. HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 121 U.K. OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 122 U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 123 U.K. CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 124 U.K. ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 125 U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 126 U.K. ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 127 U.K. FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 128 U.K. TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 129 U.K. PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 130 U.K. ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 131 U.K. PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 132 U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 133 U.K. PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 134 U.K. CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 135 U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 136 U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 137 U.K. HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 138 U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 139 FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 140 FRANCE ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 141 FRANCE STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 142 FRANCE CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 143 FRANCE CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 144 FRANCE ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 145 FRANCE INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 146 FRANCE PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 147 FRANCE HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 148 FRANCE OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 149 FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 150 FRANCE CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 151 FRANCE ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 152 FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 153 FRANCE ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 154 FRANCE FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 155 FRANCE TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 156 FRANCE PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 157 FRANCE ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 158 FRANCE PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 159 FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 160 FRANCE PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 161 FRANCE CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 162 FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 163 FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 164 FRANCE HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 165 FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 166 ITALY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 167 ITALY ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 168 ITALY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 169 ITALY CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 170 ITALY CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 171 ITALY ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 172 ITALY INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 173 ITALY PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 174 ITALY HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 175 ITALY OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 176 ITALY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 177 ITALY CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 178 ITALY ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 179 ITALY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 180 ITALY ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 181 ITALY FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 182 ITALY TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 183 ITALY PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 184 ITALY ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 185 ITALY PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 186 ITALY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 187 ITALY PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 188 ITALY CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 189 ITALY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 190 ITALY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 191 ITALY HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 192 ITALY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 193 SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 194 SPAIN ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 195 SPAIN STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 196 SPAIN CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 197 SPAIN CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 198 SPAIN ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 199 SPAIN INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 200 SPAIN PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 201 SPAIN HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 202 SPAIN OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 203 SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 204 SPAIN CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 205 SPAIN ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 206 SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 207 SPAIN ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 208 SPAIN FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 209 SPAIN TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 210 SPAIN PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 211 SPAIN ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 212 SPAIN PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 213 SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 214 SPAIN PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 215 SPAIN CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 216 SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 217 SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 218 SPAIN HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 219 SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 220 NETHERLANDS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 221 NETHERLANDS ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 222 NETHERLANDS STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 223 NETHERLANDS CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 224 NETHERLANDS CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 225 NETHERLANDS ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 226 NETHERLANDS INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 227 NETHERLANDS PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 228 NETHERLANDS HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 229 NETHERLANDS OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 230 NETHERLANDS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 231 NETHERLANDS CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 232 NETHERLANDS ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 233 NETHERLANDS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 234 NETHERLANDS ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 235 NETHERLANDS FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 236 NETHERLANDS TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 237 NETHERLANDS PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 238 NETHERLANDS ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 239 NETHERLANDS PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 240 NETHERLANDS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 241 NETHERLANDS PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 242 NETHERLANDS CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 243 NETHERLANDS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 244 NETHERLANDS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 245 NETHERLANDS HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 246 NETHERLANDS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 247 SWITZERLAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 248 SWITZERLAND ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 249 SWITZERLAND STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 250 SWITZERLAND CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 251 SWITZERLAND CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 252 SWITZERLAND ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 253 SWITZERLAND INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 254 SWITZERLAND PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 255 SWITZERLAND HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 256 SWITZERLAND OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 257 SWITZERLAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 258 SWITZERLAND CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 259 SWITZERLAND ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 260 SWITZERLAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 261 SWITZERLAND ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 262 SWITZERLAND FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 263 SWITZERLAND TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 264 SWITZERLAND PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 265 SWITZERLAND ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 266 SWITZERLAND PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 267 SWITZERLAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 268 SWITZERLAND PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 269 SWITZERLAND CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 270 SWITZERLAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 271 SWITZERLAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 272 SWITZERLAND HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 273 SWITZERLAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 274 RUSSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 275 RUSSIA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 276 RUSSIA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 277 RUSSIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 278 RUSSIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 279 RUSSIA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 280 RUSSIA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 281 RUSSIA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 282 RUSSIA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 283 RUSSIA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 284 RUSSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 285 RUSSIA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 286 RUSSIA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 287 RUSSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 288 RUSSIA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 289 RUSSIA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 290 RUSSIA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 291 RUSSIA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 292 RUSSIA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 293 RUSSIA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 294 RUSSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 295 RUSSIA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 296 RUSSIA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 297 RUSSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 298 RUSSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 299 RUSSIA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 300 RUSSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 301 TURKEY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 302 TURKEY ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 303 TURKEY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 304 TURKEY CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 305 TURKEY CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 306 TURKEY ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 307 TURKEY INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 308 TURKEY PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 309 TURKEY HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 310 TURKEY OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 311 TURKEY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 312 TURKEY CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 313 TURKEY ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 314 TURKEY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 315 TURKEY ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 316 TURKEY FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 317 TURKEY TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 318 TURKEY PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 319 TURKEY ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 320 TURKEY PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 321 TURKEY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 322 TURKEY PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 323 TURKEY CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 324 TURKEY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 325 TURKEY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 326 TURKEY HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 327 TURKEY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 328 REST OF EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

Liste des figures

FIGURE 1 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET : SEGMENTATION

FIGURE 2 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: DROC ANALYSIS

FIGURE 4 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: DBMR POSITION GRID

FIGURE 8 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: END USER COVERAGE GRID

FIGURE 10 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: SEGMENTATION

FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 INCREASED PREVALENCE OF CHRONIC CARDIAC DISEASES, RISE IN TECHNOLOGICAL ADVANCEMENTS IN NON-INVASIVE SURGERIES AND PRODUCT APPPROVALS IS EXPECTED TO DRIVE EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET FROM 2022 TO 2029

FIGURE 13 PRODUCT SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET FROM 2022 & 2029

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET

FIGURE 15 EUROPE PREVALENCE AND DISABILITY RATE OF ISCHEMIC HEART DISEASE (IHD) IN 2021

FIGURE 16 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, 2021

FIGURE 17 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, 2022-2029 (USD MILLION)

FIGURE 18 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, CAGR (2022-2029)

FIGURE 19 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 20 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, 2021

FIGURE 21 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 22 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 23 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, LIFELINE CURVE

FIGURE 24 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, 2021

FIGURE 25 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, 2022-2029 (USD MILLION)

FIGURE 26 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, CAGR (2022-2029)

FIGURE 27 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE

FIGURE 28 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, 2021

FIGURE 29 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, 2022-2029 (USD MILLION)

FIGURE 30 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, CAGR (2022-2029)

FIGURE 31 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, LIFELINE CURVE

FIGURE 32 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, 2021

FIGURE 33 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, 2022-2029 (USD MILLION)

FIGURE 34 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, CAGR (2022-2029)

FIGURE 35 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 36 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, 2021

FIGURE 37 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 38 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, CAGR (2022-2029)

FIGURE 39 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, LIFELINE CURVE

FIGURE 40 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 41 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 42 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 43 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 44 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: SNAPSHOT (2021)

FIGURE 45 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY COUNTRY (2021)

FIGURE 46 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 47 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 48 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT (2021-2029)

FIGURE 49 EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: COMPANY SHARE 2021 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The interventional cardiology and peripheral vascular devices market size will be worth USD 6,188.28 million by 2029.
The growth rate of the interventional cardiology and peripheral vascular devices market is 7.0% by 2029.
The Europe interventional cardiology and peripheral vascular devices market are the increased prevalence of coronary artery diseases, ischemic heart disease, and vascular disease, the surge in awareness about the timely treatment and use of the devices, technological advancements in the cardiology and peripheral vascular devices, increased interest towards non-invasive surgery and favorable reimbursement policies are the growth drivers of the interventional cardiology and peripheral vascular devices market.
Product, type, procedure, indication, age group, end user, and distribution channel are the factors on which the interventional cardiology and peripheral vascular devices market research is based.
Major companies in the interventional cardiology and peripheral vascular devices market are Medtronic, BD., SMT, Cordis., Abbott., Boston Scientific Corporation, Teleflex Incorporated, W.L.Gore & Associates, Inc, Cook, AngioDynamics., Edwards Lifesciences Corporation., Biosensors International Group, Ltd., OrbusNeich Medical Company Limited, Merit Medical Systems., Terumo Medical Corporation, B. Braun Melsungen AG, MicroPort Scientific Corporation, Lepu Medical Technology(Beijing)Co.,Ltd and Koninklijke Philips N.V. among others.